Aemetis (NASDAQ:AMTX) issued its quarterly earnings data on Wednesday. The specialty chemicals company reported ($0.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.31) by $0.02, MarketWatch Earnings reports. The business had revenue of $44.64 million during the quarter, compared to the consensus estimate of $43.14 million.
Shares of NASDAQ:AMTX opened at $0.97 on Friday. Aemetis has a twelve month low of $0.45 and a twelve month high of $3.12.
Several brokerages have recently weighed in on AMTX. Zacks Investment Research upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Monday, July 16th. B. Riley set a $2.00 price objective on shares of Aemetis and gave the stock a “hold” rating in a research note on Monday, August 13th.
ILLEGAL ACTIVITY NOTICE: “Aemetis (AMTX) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2018/11/09/aemetis-amtx-posts-quarterly-earnings-results-beats-estimates-by-0-02-eps.html.
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries.
Featured Story: Hedge Funds – Risk or Reward?
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.